{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nIn studies addressing cancer cell apoptosis, a central theme is the regulation of intrinsic cell death pathways by BH3 mimetics and BH3‐only proteins. For instance, one investigation demonstrated that targeting the anti‐apoptotic protein MCL‑1 with a specific BH3 mimetic can efficiently trigger apoptosis in cancer cells that rely on MCL‑1 for survival, emphasizing the complexity of BCL‑2 family interactions in modulating cell fate."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nOther reports have underscored how the balance between pro‑ and anti‑apoptotic factors determines therapeutic responses in diverse malignancies such as melanoma and hepatocellular carcinoma. In melanoma, the pro‑apoptotic BH3‑only protein Bim plays a critical role in mediating responses to BRAF inhibitors, while studies in hepatocellular carcinoma reveal that the expression pattern of BH3‑only proteins like NOXA and BIM directly affects the sensitization of tumor cells to combinations of targeted agents and pro‑apoptotic ligands."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional work has focused on novel BH3‑only factors that localize to mitochondria and interface with key components such as VDAC1 or regulate BAX/BAK activity to promote cytochrome c release and apoptosis. Similarly, in non‑small cell lung cancer, the pivotal BH3‑only protein BIM has been shown to be essential for mediating apoptosis in response to targeted therapies. It is important to note, however, that none of the provided abstracts explicitly mention or characterize a protein designated RTL10. Consequently, while the collective findings offer detailed insights into how BH3‑only–mediated interactions control apoptotic signaling in cancer, the specific function and mechanism of action of RTL10 remain unaddressed in this literature."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Georgia Greaves, Mateus Milani, Michael Butterworth, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BH3-only proteins are dispensable for apoptosis induced by pharmacological inhibition of both MCL-1 and BCL-X"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "L"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": "."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41418-018-0183-7"}], "href": "https://doi.org/10.1038/s41418-018-0183-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30185825"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30185825"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Michael Plötz, Jürgen Eberle "}, {"type": "b", "children": [{"type": "t", "text": "BH3-only proteins: possible proapoptotic triggers for melanoma therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Dermatol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/exd.12399"}], "href": "https://doi.org/10.1111/exd.12399"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24673301"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24673301"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Stephanie Busche, Katharina John, Franziska Wandrer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BH3-only protein expression determines hepatocellular carcinoma response to sorafenib-based treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-021-04020-z"}], "href": "https://doi.org/10.1038/s41419-021-04020-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34312366"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34312366"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Xiaoping Zhang, Changjiang Weng, Yuan Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human Bop is a novel BH3-only member of the Bcl-2 protein family."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Protein Cell (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13238-012-2069-7"}], "href": "https://doi.org/10.1007/s13238-012-2069-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23055042"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23055042"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Weisong Gao, Wenyan Huang, Kaishan Liu "}, {"type": "b", "children": [{"type": "t", "text": "[Effect and significance of BH3-only protein in targeted therapy of non-small cell lung cancer]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhongguo Fei Ai Za Zhi (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3779/j.issn.1009-3419.2014.11.08"}], "href": "https://doi.org/10.3779/j.issn.1009-3419.2014.11.08"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25404273"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25404273"}]}]}]}